| Other Names | BDP FL NHS ester, 146616-66-2, 3-(3-((2, 5-dioxopyrrolidin-1-yl)oxy)-3-oxopropyl)-5, 5-difluoro-7, 9-dimethyl-5H-dipyrrolo[1, 2-c:2', 1'-f][1, 3, 2]diazaborinin-4-ium-5-uide, BDY FL, SE, 1443457-56-4, 7-(3-((2, 5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropyl)-5, 5-difluoro-1, 3-dimethyl-5H-dipyrrolo[1, 2-c:2', 1'-f][1, 3, 2]diazaborinin-4-ium-5-uide, EverFluor FL, SE [4, 4-Difluoro-5, 7-DiMethyl-4-Bora-3a, 4a-Diaza-s-Indacene-3-Propionic Acid, SucciniMidyl Ester ] [Known as BODIPY[R] FL, SE, TM of MP], (2, 5-Dioxopyrrolidin-1-yl) 3-(2, 2-difluoro-10, 12-dimethyl-1-aza-3-azonia-2-boranuidatricyclo[7.3.0.03, 7]dodeca-3, 5, 7, 9, 11-pentaen-4-yl)propanoate, Boron, [1-[3-[5-[(3, 5-dimethyl-2H-pyrrol-2-ylidene-.kappa.N)methyl]-1H-pyrrol-2-yl-.kappa.N]-1-oxopropoxy]-2, 5-pyrrolidinedionato]difluoro-, (T-4, BODIPY FL Ester, MFCD00467385, BODIPY FL succinimide ester, LCZC067, C18H18BF2N3O4, SCHEMBL15334296, BDP FL NHS Ester (1mg*3), EX-A3362, AKOS025142115, AT26030, AS-77903, BP-22534, DA-61554, B6232, D5555, R01-0009, (T-4)-[1-[3-[5-[(3, 5-dimethyl-2H-pyrrol-2-ylidene-kappaN)methyl]-1H-pyrrol-2-yl-kappaN]-1-oxopropoxy]-2, 5-pyrrolidinedionato]difluoroboron, 12-{3-[(2, 5-dioxopyrrolidin-1-yl)oxy]-3-oxopropyl}-2, 2-difluoro-4, 6-dimethyl-1??, 3-diaza-2-boratricyclo[7.3.0.0(3), ?]dodeca-1(12), 4, 6, 8, 10-pentaen-1-ylium-2-uide, 2, 5-Dioxopyrrolidin-1-yl 3-(5, 5-difluoro-7, 9-dimethyl-5H-4l4, 5l4-dipyrrolo[1, 2-c:2', 1'-f][1, 3, 2]diazaborinin-3-yl)propanoate, 841-896-0 |
|---|---|
| IUPAC Name | methyl 2-[2-[2-[2-[bis(2-methoxy-2-oxoethyl)amino]phenoxy]ethoxy]-N-(2-methoxy-2-oxoethyl)-4-nitroanilino]acetate |
| CAS | 1689576-03-1 |
| Molecular Weight | 389.2 |
| Molecular Formula | C18H18BF2N3O4 |
| SMILES | [B-]1(N2C(=CC(=C2C=C3[N+]1=C(C=C3)CCC(=O)ON4C(=O)CCC4=O)C)C)(F)F |


![1H-Pyrrolo[2,3-b]pyridin-3-amine, 4-chloro- - (1000340-38-4)](https://eontrading.uk/wp-content/uploads/2025/04/1000340-38-4.png)



